Clinical Trial Update: Lifetime Risk for Cardiovascular Disease Among Non-White Ethnic Groups

View source ↗

Summary

An NHLBI-sponsored clinical trial update summarizes lifetime risk estimates for cardiovascular disease among non-white ethnic groups from a completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiovascular Disease
• Coronary Artery Disease
• Heart Failure

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Status: COMPLETED